According to QY Research Medical, the refurbished DNA sequencing platforms market size was estimated at $89.83 million in 2020, and is expected to reach $129.61 million by 2030, registering a CAGR of 2.6% from 2021 to 2030.
According to QY Research Medical, the refurbished DNA sequencing platforms market size was estimated at $89.83 million in 2020, and is expected to reach $129.61 million by 2030, registering a CAGR of 2.6% from 2021 to 2030.
DNA sequencing is the process of determining the nucleic acid sequence, which is the order of nucleotides in DNA. It includes any method or technology that is used to determine the order of the four bases, namely adenine, guanine, cytosine, and thymine. Refurbished DNA sequencing platforms are comparatively less expensive as compared to new platforms. DNA sequencing is used to execute various applications, such as biomarker discovery, oncology studies, personalized medicine, forensics, and others. It has streamlined nucleotide analysis and consists of widely replaced conventional tools of genomics, especially microarray, genotyping, and others.
Full Report is Ready | Request Sample of This Report @ https://qyresearchmedical.com/sample/112655
Increase in demand for DNA sequencing owing to surge in sequencing applications drives the growth of the refurbished DNA sequencing platforms market. In addition, the growth in number of genome mapping programs globally and increase in R&D investment further fuel growth of the refurbished DNA sequencing platforms market. However, dearth of skilled professionals, ethical & legal limitation related to DNA sequencing, and standardization concerns in sequencing procedures may hamper growth of the market. Conversely, use of cloud computing as a potential data management service and the untapped emerging countries are expected to offer profitable opportunities for the growth of the market during the forecast period.
What Is The Impact Of Covid-19 Pandemic On The Refurbished Dna Sequencing Platforms Market?
The outbreak of COVID-19 has disrupted workflows in the healthcare sector globally. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. In the initial days of the COVID-19 pandemic, in 2020, some countries were in lockdown. They banned trade with other nations and enforced travel restrictions, resulting in fall in diagnostics and surgical procedures in the first half of 2020.
Scope of the Report
| Report Coverage | Details |
| Market Size in 2020 | $89.83 Million |
| Revenue Forecast by 2030 | $129.61 Million |
| CAGR | 2.6% from 2021 to 2030 |
| Base Year | 2021 |
| Forecast Data | 2022 to 2030 |
The COVID-19 outbreak is anticipated to have a positive impact on growth of the global refurbished DNA sequencing platforms market. The COVID-19 pandemic has stressed the healthcare system in globally and increased the need to identify the strain of new coronavirus. Next generation sequencing offers an effective and unbiased way to identify the new strain of corona virus. A huge number of researches were conducted on DNA and RNA of corona virus to understand how it enters human cells and to learn about its pathogenesis. Although qPCR technology can be used for the detection and used in quantification of COVID-19 in the pandemic, but it has a major disadvantage. qPCR cannot be used to decipher any mutations or changes in the entire viral genome.
Full Report is Ready | Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112655/2900
Next generation sequencing systems play a vital role in studying the mutations in the viral genome and their impact on human health. As per research published by Clinical OMICS in 2020, there were approximately 84,000 viral genomic sequences of the coronavirus uploaded to Global Initiative to Share All Influenza Data (GISAID) by August 2020, and the analysis of 4,641 genomes revealed that the virus continues to mutate as it spreads with one or two base changes per month. Next generation sequencing helps in understanding the evolving process of the COVID virus. It also helps in keeping a track over the transmission of the virus globally.
The COVID-19 pandemic is expected to significantly have a positive impact on the growth of the global next generation sequencing industry. Similarly, the demand for refurbished products is slowly gaining traction and due to the positive impact of COVID-19. In addition, it is expected that individuals from research laboratories, who are comparatively underfunded can avail refurbished DNA sequencing platforms in the coming years due to its low price as compared to the new DNA sequencing platforms.
Refurbished Dna Sequencing Platforms Market Segmentation
The refurbished DNA sequencing platforms market is segmented on the basis of region. On the basis of region, the market is analyzed across North America, Europe, and RoW. RoW constituted the highest market share in the global refurbished DNA sequencing platforms market in 2020, followed by Europe and North America. North America is expected to register fastest growth rate during the forecast period, owing to the presence of high per capita healthcare expenditure coupled with high patient awareness levels and high prevalence of target diseases.
On the other hand, Europe is expected to witness considerable market growth during the forecast period, due to increase in demand for DNA sequencing and strong presence of key players
The key market players profiled in the report include Abbott Laboratories, Agilent Technologies Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd., Illumina Inc., Li-Cor Biosciences, Inc., Macrogen Inc., Pacific Biosciences of California, Inc., PerkinElmer Inc., and Thermo Fisher Scientific, Inc.
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the global refurbished DNA sequencing platforms market along with the current trends and future estimations to explain the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing refurbished DNA sequencing platforms market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of refurbished DNA sequencing platforms used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the refurbished DNA sequencing platforms market.
Key Market Segments
- By Region
- North America
- Europe
- RoW (Rest of the World)
Full Report is Ready | Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112655/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/